In preparation for impending retirement of Exec VP Donald O'Neill, company made series of organization moves: Parke-Davis President Joseph Smith and International Operations President John Walsh promoted to exec VPs; Lodewijk de Vink, exec VP and president of U.S. operations, will succeed O'Neill as chairman of the pharmaceutical review board. Novon Products President Philip Gross will report to President and Chief Operating Officer Mel Goodes.
You may also be interested in...
While it was not as affected as some other countries, Japan still had the pandemic to deal with and regulators responded while managing to keep up regular product review work, including several world-first approvals. Coronavirus vaccine roll-outs and the first general annual reimbursement price cut are on the cards for this year.
The recently US FDA-cleared Velys robotic-assisted system from DePuy Synthes has distinct features. It also has a small footprint that makes it well-suited for ambulatory surgery centers. See what Larry Biegelsen, an analyst with Wells Fargo, said about it here.
The tactic aims to allow the new Biden administration to scrutinize so-called “midnight rules” issued in the final days of the Trump administration before they take effect. One reg targeted by the freeze is the recent SUNSET rule from the HHS, which would require the department and its agencies – including the FDA – to review all regulations every 10 years to determine whether they’re still necessary.